| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
Mofarotene manufacturers
- Mofarotene
-
- $46.00
-
2026-07-27
- CAS:125533-88-2
- Purity: 99.96%
- Supply Ability: 10g
|
| | Mofarotene Basic information |
| Product Name: | Mofarotene | | Synonyms: | 4-[2-[4-[(E)-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]phenoxy]ethyl]morpholine;Mofarotene | | CAS: | 125533-88-2 | | MF: | C29H39NO2 | | MW: | 433.632 | | EINECS: | | | Product Categories: | | | Mol File: | 125533-88-2.mol |  |
| | Mofarotene Chemical Properties |
| | Mofarotene Usage And Synthesis |
| Uses | Mofarotene (Ro 40-8757), an arotinoid, is anticancer compound. Mofarotene induces apoptosis, associated with mitochondrial membrane depolarization, activation of caspase-3 and -9, and enhanced production of reactive oxygen species. Mofarotene inhibits hematopoiesis in vitro by inhibiting maturation from primitive progenitor cells[1][2][3]. | | IC 50 | Caspase 3; Caspase-9 | | References | [1] Valles B, et al. Metabolism of mofarotene in hepatocytes and liver microsomes from different species. Comparison with in vivo data and evaluation of the cytochrome P450 isoenzymes involved in human biotransformation. Drug Metab Dispos. 1995 Oct;23(10):1051-7. PMID:8654192
[2] Eliason JF, et al. Mofarotene (Ro 40-8757) inhibits hematopoiesis in vitro by preventing maturation from primitive progenitor cells. Blood. 1995 Dec 15;86(12):4516-26. PMID:8541541
[3] Cariati R, et al. Inhibition of oxidative phosphorylation underlies the antiproliferative and proapoptotic effects of mofarotene (Ro 40-8757) in Burkitt's lymphoma cells. Oncogene. 2003 Feb 13;22(6):906-18. DOI:10.1038/sj.onc.1206060 |
| | Mofarotene Preparation Products And Raw materials |
|